Cargando…
Antireflux Endoluminal Therapies: Past and Present
The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723090/ https://www.ncbi.nlm.nih.gov/pubmed/23935608 http://dx.doi.org/10.1155/2013/481417 |
_version_ | 1782278256870817792 |
---|---|
author | Yew, Kuo Chao Chuah, Seng-Kee |
author_facet | Yew, Kuo Chao Chuah, Seng-Kee |
author_sort | Yew, Kuo Chao |
collection | PubMed |
description | The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are 3 commonly employed anti-reflux endoluminal procedures: fundoplication or suturing techniques (EndoCinch, NDO, and EsophyX), intramural injection or implant techniques (enhancing lower esophageal sphincter (LES) volume and/or strengthening compliance of the LES-Enteryx and Gatekeeper), and radiofrequency ablation of LES and cardia. EndoCinch plication requires further study and modification of technique before it can be recommended because of durability issues. Esophynx, the transoral incisionless fundoplication, may reduce hiatal hernias and increase LES length. Preliminary studies have shown promising reduction in symptoms and medication use but evidence concerning safety and long-term durability is still pending. The safety issue with injection technique is the main concern as evident from the incidences of implant withdrawals after reported major adverse events. Future research with cautious monitoring is required before any new implant material can be recommended for commercial application. Radiofrequency ablation therapy is regaining popularity in treating refractory symptoms despite PPI use due to improved efficacy, durability, and safety after years of refinement of protocol. |
format | Online Article Text |
id | pubmed-3723090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37230902013-08-09 Antireflux Endoluminal Therapies: Past and Present Yew, Kuo Chao Chuah, Seng-Kee Gastroenterol Res Pract Review Article The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are 3 commonly employed anti-reflux endoluminal procedures: fundoplication or suturing techniques (EndoCinch, NDO, and EsophyX), intramural injection or implant techniques (enhancing lower esophageal sphincter (LES) volume and/or strengthening compliance of the LES-Enteryx and Gatekeeper), and radiofrequency ablation of LES and cardia. EndoCinch plication requires further study and modification of technique before it can be recommended because of durability issues. Esophynx, the transoral incisionless fundoplication, may reduce hiatal hernias and increase LES length. Preliminary studies have shown promising reduction in symptoms and medication use but evidence concerning safety and long-term durability is still pending. The safety issue with injection technique is the main concern as evident from the incidences of implant withdrawals after reported major adverse events. Future research with cautious monitoring is required before any new implant material can be recommended for commercial application. Radiofrequency ablation therapy is regaining popularity in treating refractory symptoms despite PPI use due to improved efficacy, durability, and safety after years of refinement of protocol. Hindawi Publishing Corporation 2013 2013-07-09 /pmc/articles/PMC3723090/ /pubmed/23935608 http://dx.doi.org/10.1155/2013/481417 Text en Copyright © 2013 K. C. Yew and S.-K. Chuah. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Yew, Kuo Chao Chuah, Seng-Kee Antireflux Endoluminal Therapies: Past and Present |
title | Antireflux Endoluminal Therapies: Past and Present |
title_full | Antireflux Endoluminal Therapies: Past and Present |
title_fullStr | Antireflux Endoluminal Therapies: Past and Present |
title_full_unstemmed | Antireflux Endoluminal Therapies: Past and Present |
title_short | Antireflux Endoluminal Therapies: Past and Present |
title_sort | antireflux endoluminal therapies: past and present |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723090/ https://www.ncbi.nlm.nih.gov/pubmed/23935608 http://dx.doi.org/10.1155/2013/481417 |
work_keys_str_mv | AT yewkuochao antirefluxendoluminaltherapiespastandpresent AT chuahsengkee antirefluxendoluminaltherapiespastandpresent |